The store will not work correctly when cookies are disabled.
3-(2-Methoxyphenyl)-4-(naphthalen-1-ylamino)-1H-pyrrole-2,5-dione
ID: ALA4877889
PubChem CID: 164627086
Max Phase: Preclinical
Molecular Formula: C21H16N2O3
Molecular Weight: 344.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1C1=C(Nc2cccc3ccccc23)C(=O)NC1=O
Standard InChI: InChI=1S/C21H16N2O3/c1-26-17-12-5-4-10-15(17)18-19(21(25)23-20(18)24)22-16-11-6-8-13-7-2-3-9-14(13)16/h2-12H,1H3,(H2,22,23,24,25)
Standard InChI Key: AFLQKPBFQDXTFP-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
20.1605 -23.9576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9777 -23.9576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2320 -23.1809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5691 -22.6988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9103 -23.1809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7360 -24.6559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9167 -24.6360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4917 -25.3346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8848 -26.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7073 -26.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1286 -25.3702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4572 -24.6193 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2705 -24.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6757 -25.3254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4882 -25.3253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0096 -22.9295 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1330 -22.9287 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5249 -23.9189 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7080 -23.8996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8973 -24.6207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6728 -23.9173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4816 -23.9164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8835 -23.2166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4776 -22.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6658 -22.5221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2676 -23.2224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 20 2 0
21 13 1 0
3 16 2 0
5 17 2 0
7 18 1 0
18 19 1 0
22 20 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 21 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.37 | Molecular Weight (Monoisotopic): 344.1161 | AlogP: 3.33 | #Rotatable Bonds: 4 |
Polar Surface Area: 67.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.56 | CX Basic pKa: ┄ | CX LogP: 2.78 | CX LogD: 2.78 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.71 | Np Likeness Score: -0.20 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |